Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2015

01-02-2015 | Original Article

Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case–control study

Authors: Illaparambath Rahul, Sriram Krishnamurthy, Santhosh Satheesh, Niranjan Biswal, Zachariah Bobby, Subitha Lakshminarayanan

Published in: Clinical and Experimental Nephrology | Issue 1/2015

Login to get access

Abstract

Background

Children with nephrotic syndrome (NS) have hyperlipidemia, which may lead to endothelial dysfunction. This study evaluated endothelial function and structural atherosclerosis in NS children with disease duration more than 2 years, by assessment of brachial artery flow-mediated dilatation (FMD) and carotid intima medial thickness (CIMT).

Methods

This is a cross-sectional case–control study recruiting 32 subjects aged 1–13 years with NS and 32 matched controls. Clinical details, FMD and CIMT were recorded. Lipid profile and oxidative stress were also analyzed in the subjects.

Results

The proportionate change in FMD was significantly lower in cases (5.65 ± 6.08 %) compared to controls (15.21 ± 9.41 %) (p < 0.01). No significant differences in CIMT were observed (p = 0.383). Blood malondialdehyde was significantly higher (p = 0.006) in the cases. Overall, 25 NS children (78 %) were in remission for more than 6 months, and in them, 9 (36 %) had deranged lipid profile. On stepwise linear regression, age of the patient was found to be a determinant of FMD (model R 2 = 18.9 %, p value = 0.048).

Conclusion

The significantly low proportionate change in FMD in NS children suggests an ongoing process of endothelial dysfunction. Further studies are needed to confirm these findings. A long-term follow-up of children with NS may be required for identification of CIMT derangements.
Literature
1.
go back to reference Mérouani A, Lévy E, Mongeau J-G, Robitaille P, Lambert M, Delvin EE. Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem. 2003;36:571–4.CrossRefPubMed Mérouani A, Lévy E, Mongeau J-G, Robitaille P, Lambert M, Delvin EE. Hyperlipidemic profiles during remission in childhood idiopathic nephrotic syndrome. Clin Biochem. 2003;36:571–4.CrossRefPubMed
2.
go back to reference Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr. 1984;104:61–4.CrossRefPubMed Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr. 1984;104:61–4.CrossRefPubMed
3.
go back to reference Kniazewska MH, Obuchowicz AK, Wielkoszyński T, Zmudzińska-Kitczak J, Urban K, Marek M, et al. Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol. 2009;24:549–54.CrossRefPubMed Kniazewska MH, Obuchowicz AK, Wielkoszyński T, Zmudzińska-Kitczak J, Urban K, Marek M, et al. Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol. 2009;24:549–54.CrossRefPubMed
4.
go back to reference Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–5.CrossRefPubMed Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–5.CrossRefPubMed
5.
go back to reference Spence JD. Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;2:611–9.CrossRefPubMed Spence JD. Technology Insight: ultrasound measurement of carotid plaque—patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol. 2006;2:611–9.CrossRefPubMed
6.
go back to reference Sutter JD, Bacquer DD, Kotseva K, Sans S, Pyörälä K, Wood D, et al. Screening of family members of patients with premature coronary heart disease results from the EUROASPIRE II family survey. Eur Heart J. 2003;24:249–57.CrossRefPubMed Sutter JD, Bacquer DD, Kotseva K, Sans S, Pyörälä K, Wood D, et al. Screening of family members of patients with premature coronary heart disease results from the EUROASPIRE II family survey. Eur Heart J. 2003;24:249–57.CrossRefPubMed
7.
go back to reference Ceriotti F, Boyd JC, Klein G, Henny J, Queraltó J, Kairisto V, et al. Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem. 2008;54:559–66.CrossRefPubMed Ceriotti F, Boyd JC, Klein G, Henny J, Queraltó J, Kairisto V, et al. Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clin Chem. 2008;54:559–66.CrossRefPubMed
8.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.CrossRef
9.
go back to reference The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98:561–4.CrossRef The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98:561–4.CrossRef
11.
go back to reference Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–5.PubMed Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–5.PubMed
12.
go back to reference Williams P, Robinson D, Bailey A. High-density lipoprotein and coronary risk factors in normal men. Lancet. 1979;1:72–5.CrossRefPubMed Williams P, Robinson D, Bailey A. High-density lipoprotein and coronary risk factors in normal men. Lancet. 1979;1:72–5.CrossRefPubMed
13.
go back to reference Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed
14.
go back to reference Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol Clifton NJ. 1998;108:101–6. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol Clifton NJ. 1998;108:101–6.
15.
go back to reference Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res. 1996;25:57–74.CrossRefPubMed Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res. 1996;25:57–74.CrossRefPubMed
16.
go back to reference Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–65.CrossRefPubMed Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–65.CrossRefPubMed
17.
go back to reference Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk. 2002;9:97–103.CrossRefPubMed Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk. 2002;9:97–103.CrossRefPubMed
18.
go back to reference Caraba A, Romoşan I. Endothelial dysfunction in the nephrotic syndrome. Med Pregl. 2007;60(Suppl 2):66–9.PubMed Caraba A, Romoşan I. Endothelial dysfunction in the nephrotic syndrome. Med Pregl. 2007;60(Suppl 2):66–9.PubMed
19.
go back to reference Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–78.CrossRefPubMed Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–78.CrossRefPubMed
20.
go back to reference Neunteufl T, Heher S, Katzenschlager R, Wölfl G, Kostner K, Maurer G, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86:207–10.CrossRefPubMed Neunteufl T, Heher S, Katzenschlager R, Wölfl G, Kostner K, Maurer G, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol. 2000;86:207–10.CrossRefPubMed
21.
go back to reference Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–54.CrossRefPubMed Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948–54.CrossRefPubMed
22.
go back to reference Pełkowska A, Sancewicz-Pach K. Determination of endothelial function in children with nephrotic syndrome in various states of disease. Wiad Lek. 2005;58(Suppl 1):35–8.PubMed Pełkowska A, Sancewicz-Pach K. Determination of endothelial function in children with nephrotic syndrome in various states of disease. Wiad Lek. 2005;58(Suppl 1):35–8.PubMed
23.
go back to reference Dogra GK, Herrmann S, Irish AB, Thomas MAB, Watts GF. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant. 2002;17:2220–5.CrossRefPubMed Dogra GK, Herrmann S, Irish AB, Thomas MAB, Watts GF. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant. 2002;17:2220–5.CrossRefPubMed
24.
go back to reference Watts GF, Herrmann S, Dogra GK, Playford DA, Best JD, Thomas MAB, et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int. 2001;60:182–9.CrossRefPubMed Watts GF, Herrmann S, Dogra GK, Playford DA, Best JD, Thomas MAB, et al. Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int. 2001;60:182–9.CrossRefPubMed
25.
go back to reference Wilson AC, Urbina E, Witt SA, Glascock BJ, Kimball TR, Mitsnefes M. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr Nephrol. 2008;23:1297–302.CrossRefPubMed Wilson AC, Urbina E, Witt SA, Glascock BJ, Kimball TR, Mitsnefes M. Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease. Pediatr Nephrol. 2008;23:1297–302.CrossRefPubMed
26.
go back to reference Leeson CP, Whincup PH, Cook DG, Donald AE, Papacosta O, Lucas A, Deanfield JE. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation. 1997;96:2233–8.CrossRefPubMed Leeson CP, Whincup PH, Cook DG, Donald AE, Papacosta O, Lucas A, Deanfield JE. Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation. 1997;96:2233–8.CrossRefPubMed
27.
go back to reference Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–9.CrossRefPubMed Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–9.CrossRefPubMed
28.
go back to reference Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96:1432–7.CrossRefPubMed Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96:1432–7.CrossRefPubMed
29.
go back to reference Suys B, de Beeck LOP, Rooman R, Kransfeld S, Heuten H, Goovaerts I, et al. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatr Res. 2007;62:456–61.CrossRefPubMed Suys B, de Beeck LOP, Rooman R, Kransfeld S, Heuten H, Goovaerts I, et al. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase? Pediatr Res. 2007;62:456–61.CrossRefPubMed
30.
go back to reference Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 1995;77:510–8.CrossRefPubMed Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 1995;77:510–8.CrossRefPubMed
31.
go back to reference Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002;29:292–7.PubMed Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2002;29:292–7.PubMed
32.
go back to reference Hafström I, Rohani M, Deneberg S, Wörnert M, Jogestrand T, Frostegård J. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis—a randomized study. J Rheumatol. 2007;34:1810–6.PubMed Hafström I, Rohani M, Deneberg S, Wörnert M, Jogestrand T, Frostegård J. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis—a randomized study. J Rheumatol. 2007;34:1810–6.PubMed
Metadata
Title
Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case–control study
Authors
Illaparambath Rahul
Sriram Krishnamurthy
Santhosh Satheesh
Niranjan Biswal
Zachariah Bobby
Subitha Lakshminarayanan
Publication date
01-02-2015
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2015
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-0958-1

Other articles of this Issue 1/2015

Clinical and Experimental Nephrology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.